#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	618	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1046	31.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	291	293	ACG	27;28;28	A;C;G	27;28;28	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	T879G	SNP	879	879	T	27	27	G	1	G	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	G880A	SNP	880	880	G	28	28	A	1	A	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	A888G	SNP	888	888	A	36	36	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	C897G	SNP	897	897	C	45	45	G	11	G	11	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	T898C	SNP	898	898	T	46	46	C	11	C	11	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	G906T	SNP	906	906	G	54	54	T	19	T	19	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	G908A	SNP	908	908	G	56	56	A	18	A	18	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	A918T	SNP	918	918	A	66	66	T	24	T	23	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	A943G	SNP	943	943	A	91	91	G	64	G	64	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	308	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c17.ctg.1	153	24.3	0	.	n	.	0	G991T	SNP	991	991	G	139	139	T	32	T	31	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	155	2078	Escherichia_coli_EF_Tu	1185	1185	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1605	66.2	0	HET	.	.	.	T135C	.	135	135	T	396	396	T	62	T,C	36,21	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	155	2078	Escherichia_coli_EF_Tu	1185	1185	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1605	66.2	0	HET	.	.	.	T1167A	.	1167	1167	T	1428	1428	T	43	T,A	27,16	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	155	2078	Escherichia_coli_EF_Tu	1185	1185	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1605	66.2	0	HET	.	.	.	T1170A	.	1170	1170	T	1431	1431	T	41	T,A	25,16	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	155	2078	Escherichia_coli_EF_Tu	1185	1185	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1605	66.2	0	HET	.	.	.	C216T	.	216	216	C	477	477	C	73	C,T	42,31	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	155	2078	Escherichia_coli_EF_Tu	1185	1185	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1605	66.2	0	HET	.	.	.	C954T	.	954	954	C	1215	1215	C	87	C,T	42,42	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	710	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1750	21.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1562	1564	AAA	13;12;12	A;A;A	13;12;12	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	932	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1649	30.1	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1247	1249	GAA	35;35;33	G;A;A	35;35;33	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	226	H_NS	414	414	99.03	H_NS.l15.c4.ctg.1	830	14.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	107	G	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	109	T	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	122	G	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	116	C	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	112	C	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	110	T	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	134	C	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	112	C	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	113	A	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	111	A	110	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	112	A	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	103	T	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	101	C	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	88	C	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	85	A	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	75	G	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	74	C	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	65	T	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	97	G	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	106	G	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	108	T	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	147	T	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	142	G	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	117	C,A	115,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	111	A	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	61	C	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	51	C	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	4	G	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	24	C	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	62	T	62	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	73	G	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	43	T	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	125	C	124	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2528	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l6.c30.ctg.2	531	119.5	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	103	C,T	59,15	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	814	PmrB_1	1092	1092	99.27	PmrB_1.l6.c30.ctg.1	1485	29.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	184	186	CGT	30;31;31	C;G;T	30;31;31	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	814	PmrB_1	1092	1092	99.27	PmrB_1.l6.c30.ctg.1	1485	29.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1027	1029	GGC	27;26;26	G;G;C	27;26;26	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2016	28.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	176	178	AGC	17;16;15	A;G;C	17;15;15	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2016	28.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	578	580	CTA	31;31;30	C;T;A	31;31;30	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2016	28.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1097	1099	CAA	45;44;45	C;A;A	44;43;45	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2016	28.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1196	1198	GGT	35;36;35	G;G;T	35;36;35	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2016	28.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1766	1768	GTT	22;21;21	G;T;T	22;21;20	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	470	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1504	16.8	0	.	p	.	0	A125E	NONSYN	373	375	GCA	527	529	GAA	20;20;20	G;A;A	20;20;20	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	470	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1504	16.8	0	.	p	.	0	M185T	NONSYN	553	555	ATG	707	709	ACC	7;7;7	A;C;C	7;7;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	470	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1504	16.8	0	.	p	.	0	S225T	NONSYN	673	675	TCC	827	829	ACT	9;8;7	A;C;T	9;8;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	470	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1504	16.8	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1217	1219	ATC	17;18;19	A;T;C	15;17;19	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	539	524	PmrF	969	969	99.28	PmrF.l15.c4.ctg.1	1396	20.2	0	.	p	.	0	R137L	NONSYN	409	411	CGT	609	611	CTT	21;22;21	C;T;T	21;22;21	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	528	48	TEM_1+	858	202	99.01	TEM_1+.l15.c30.ctg.1	212	3.6	0	.	p	.	0	K4Q	NONSYN	10	12	AAA	20	22	CAA	1;1;1	C;A;A	1;1;1	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1718	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3527	26.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	467	469	ATC	19;18;17	A;T;C	19;18;17	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1718	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3527	26.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2180	2182	AAG	22;22;23	A;A;G	22;22;23	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	832	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1573	28.3	0	.	p	.	0	A22V	NONSYN	64	66	GCC	255	257	GTC	9;9;11	G;T;C	9;9;11	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	832	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1573	28.3	0	.	p	.	0	S269C	NONSYN	805	807	AGC	996	998	TGC	46;48;48	T;G;C	46;48;48	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2050	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3475	31.6	0	.	p	.	0	S46trunc	TRUNC	136	136	T	342	342	T	17	T	17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2050	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3475	31.6	0	.	p	.	0	G148D	NONSYN	442	444	GGC	648	650	GAC	31;31;31	G;A;C	31;31;29	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2050	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3475	31.6	0	.	p	.	0	F240L	NONSYN	718	720	TTT	924	926	TTA	19;21;20	T;T;A	19;21;20	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2050	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3475	31.6	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2001	2003	AAT	37;39;40	A;A;T	37;38;40	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2050	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3475	31.6	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2115	2117	AGT	29;27;27	A;G;T	29;27;27	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2050	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3475	31.6	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2514	2516	GTG	21;21;22	G;T;G	21;21;22	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2050	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3475	31.6	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3069	3071	AAG	30;29;29	A;A;G	30;29;29	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	402	acrR_2	648	648	99.54	acrR_2.l15.c17.ctg.1	1067	20.3	1	SNP	p	R45C	0	.	.	133	135	CGC	329	331	CGC	22;19;18	C;G;C	22;19;18	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	404	acrS	663	663	98.79	acrS.l6.c4.ctg.1	997	21.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	240	242	TTC	29;29;28	T;T;C	29;29;28	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	404	acrS	663	663	98.79	acrS.l6.c4.ctg.1	997	21.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	504	506	GGG	30;29;29	G;G;G	30;28;29	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	574	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1181	26.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	640	642	CTT	44;44;44	C;T;T	44;44;44	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1814	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2995	32.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2025	2027	GCA	40;42;43	G;C,G;A	40;39,1;41	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1814	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2995	32.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2286	2288	ACC	29;29;29	A;C;C	29;29;29	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1814	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2995	32.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2595	2597	GCC	24;25;24	G;C;C	24;25;24	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	888	arnA_1	1983	1728	98.44	arnA_1.l15.c17.ctg.1	1899	23.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	10	12	TGC	4;4;5	T;G;C	4;4;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	888	arnA_1	1983	1728	98.44	arnA_1.l15.c17.ctg.1	1899	23.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	193	195	GTT	19;19;19	G;T;T	19;19;18	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	888	arnA_1	1983	1728	98.44	arnA_1.l15.c17.ctg.1	1899	23.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	343	345	CAC	17;16;16	C;A;C	17;16;16	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	888	arnA_1	1983	1728	98.44	arnA_1.l15.c17.ctg.1	1899	23.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	628	630	ATG	35;36;35	A;T;G	35;35;35	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	888	arnA_1	1983	1728	98.44	arnA_1.l15.c17.ctg.1	1899	23.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1624	1626	CGC	27;28;27	C;G;C	27;28;27	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	888	arnA_1	1983	108	98.15	arnA_1.l15.c17.ctg.2	236	5.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	888	arnA_1	1983	143	97.2	arnA_1.l15.c17.ctg.3	143	10.1	0	.	p	.	0	D77E	NONSYN	229	231	GAT	115	117	GAG	2;2;2	G;A;G	2;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	362	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1075	17.1	0	.	p	.	0	S221T	NONSYN	661	663	AGC	758	760	ACC	14;14;14	A;C;C	14;14;14	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	362	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1075	17.1	0	.	p	.	0	P225S	NONSYN	673	675	CCG	770	772	TCG	17;17;17	T;C;G	17;17;17	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	531	386	baeR	723	681	97.65	baeR.l15.c4.ctg.1	894	21.6	0	.	p	.	0	S214F	NONSYN	640	642	TCT	853	855	TTT	12;12;12	T;T;T	12;12;12	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	642	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1554	21.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1263	1265	AAA	10;9;9	A;A;A	10;9;9	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	642	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1554	21.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1275	1277	GAG	6;6;6	G;A;G	6;5;6	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	642	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1554	21.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1281	1283	CAC	8;9;9	C;A;C	7;9;9	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	642	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1554	21.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1335	1337	GAG	17;16;16	G;A;G	17;16;16	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	848	cpxA	1374	1374	98.76	cpxA.l15.c4.ctg.1	1771	25.7	0	.	p	.	0	A231T	NONSYN	691	693	GCG	892	894	ACG	26;27;27	A,G;C;G	25,1;27;26	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	636	cpxR	699	699	99.43	cpxR.l6.c30.ctg.1	1104	30.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	564	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1358	22.4	0	.	p	.	0	T132I	NONSYN	394	396	ACA	573	575	ATA	43;43;42	A;T,C;A	42;39,3;41	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	662	emrA	1173	1173	98.38	emrA.l6.c30.ctg.1	1463	23.8	0	.	p	.	0	I219V	NONSYN	655	657	ATC	863	865	GTC	34;34;35	G;T;C	33;34;35	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1012	emrB	1539	1539	99.81	emrB.l15.c30.ctg.1	1963	27.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	766	emrD	1191	1191	98.57	emrD.l6.c4.ctg.1	1616	25.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	857	859	AGC	16;16;15	A;G;C	16;16;15	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	512	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1225	20.9	0	.	p	.	0	K176R	NONSYN	526	528	AAG	675	677	AGG	21;21;21	A;G;G	21;21;21	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	512	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1225	20.9	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1065	1067	GAC	16;16;16	G;A;C	16;16;16	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	346	emrR	531	531	100.0	emrR.l15.c30.ctg.1	933	20.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	838	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1956	23.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	298	evgA	615	615	99.19	evgA.l15.c4.ctg.1	862	18.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	247	249	CTG	31;31;32	C,A;T;G	30,1;31;32	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	317	319	ATA	7;7;7	A;T;A	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	329	331	GTA	8;9;10	G;T;A	8;9;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	482	484	ACG	11;11;14	A;C;G	11;11;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	545	547	GAA	25;25;25	G;A;A	25;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	584	586	GCT	29;30;30	G;C;T	29;30;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	602	604	GAT	24;23;23	G;A;T	24;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	689	691	TCA	8;9;9	T;C;A	8;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	818	820	CAG	17;18;19	C;A;G	17;18;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	956	958	GTT	16;15;15	G;T;T	16;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1112	1114	GAT	9;9;9	G;A;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1280	1282	AAT	13;13;13	A;A;T	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1301	1303	TTA	3;3;2	T;T;A	3;3;2	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1502	1504	AAA	18;18;18	A;A;A	18;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2237	2239	CAT	19;18;18	C;A;T	19;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2291	2293	CAT	13;14;15	C;A;T	13;14;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2309	2311	AGA	23;22;22	A;G;A	23;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2324	2326	AAT	25;25;24	A;A;T	25;25;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2471	2473	TCC	16;14;15	T;C;C	16;14;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2636	2638	ATT	16;16;16	A;T;T	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2657	2659	GAT	21;20;21	G;A;T	21;20;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2771	2773	GTT	19;19;19	G;T;T	19;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1500	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	3978	20.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3056	3058	CAC	18;18;18	C;A;C	18;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	482	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1301	19.9	1	SNP	p	P64H	0	.	.	190	192	CCA	437	439	CCA	37;37;35	C;C;A	37;37;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	482	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1301	19.9	1	SNP	p	P64L	0	.	.	190	192	CCA	437	439	CCA	37;37;35	C;C;A	37;37;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	482	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1301	19.9	1	SNP	p	P64R	0	.	.	190	192	CCA	437	439	CCA	37;37;35	C;C;A	37;37;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	482	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1301	19.9	1	SNP	p	P64A	0	.	.	190	192	CCA	437	439	CCA	37;37;35	C;C;A	37;37;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	482	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1301	19.9	1	SNP	p	P64S	0	.	.	190	192	CCA	437	439	CCA	37;37;35	C;C;A	37;37;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	358	gadE	528	528	100.0	gadE.l15.c17.ctg.1	910	21.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	228	96.05	gadW.l15.c4.ctg.1	324	14.0	0	.	p	.	0	S234A	NONSYN	700	702	TCG	199	201	GCG	13;12;12	G;C;G	12;12;12	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	300	93.0	gadW.l15.c4.ctg.2	300	8.1	0	.	p	.	0	E54D	NONSYN	160	162	GAA	2	4	GAT	3;4;4	G;A;T	3;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	300	93.0	gadW.l15.c4.ctg.2	300	8.1	0	.	p	.	0	I88M	NONSYN	262	264	ATA	104	106	ATG	5;5;5	A;T;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	300	93.0	gadW.l15.c4.ctg.2	300	8.1	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	107	109	CCG	5;5;5	C;C;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	300	93.0	gadW.l15.c4.ctg.2	300	8.1	0	.	p	.	0	D100E	NONSYN	298	300	GAC	140	142	GAA	3;1;1	G;A;A	3;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	300	93.0	gadW.l15.c4.ctg.2	300	8.1	0	.	p	.	0	P101S	NONSYN	301	303	CCC	143	145	TCC	1;2;2	T;C;C	1;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	300	93.0	gadW.l15.c4.ctg.2	300	8.1	0	.	p	.	0	R102G	NONSYN	304	306	CGG	146	148	GGG	2;2;2	G;G;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	300	93.0	gadW.l15.c4.ctg.2	300	8.1	0	.	p	.	0	K110N	NONSYN	328	330	AAA	170	172	AAT	4;3;4	A;A;T	4;3;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	418	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1156	19.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	308	310	TTA	20;20;20	T;T;A	20;20;20	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	418	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1156	19.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	386	388	ATT	19;18;17	A;T;T	19;18;17	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	418	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1156	19.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	887	889	GGA	27;26;25	G;G;A	27;26;25	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	418	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1156	19.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	893	895	CCG	25;24;24	C;C;G	25;24;24	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2247	2249	GAA	25;24;28	G;A;A	25;23;27	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	1	SNP	p	S83L	0	.	.	247	249	TCG	462	464	TCG	46;47;50	T;C;G	43;46;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	1	SNP	p	S83I	0	.	.	247	249	TCG	462	464	TCG	46;47;50	T;C;G	43;46;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	1	SNP	p	S83W	0	.	.	247	249	TCG	462	464	TCG	46;47;50	T;C;G	43;46;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	1	SNP	p	D87Y	0	.	.	259	261	GAC	474	476	GAC	40;40;41	G;A;C	39;40;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	1	SNP	p	D87N	0	.	.	259	261	GAC	474	476	GAC	40;40;41	G;A;C	39;40;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	1	SNP	p	D87H	0	.	.	259	261	GAC	474	476	GAC	40;40;41	G;A;C	39;40;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	1	SNP	p	D87G	0	.	.	259	261	GAC	474	476	GAC	40;40;41	G;A;C	39;40;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1732	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3095	30.2	1	SNP	p	D87V	0	.	.	259	261	GAC	474	476	GAC	40;40;41	G;A;C	39;40;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1594	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2849	30.1	1	SNP	p	R136C	0	.	.	406	408	CGC	614	616	CGC	29;29;28	C;G;C	27;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1594	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2849	30.1	1	SNP	p	R136S	0	.	.	406	408	CGC	614	616	CGC	29;29;28	C;G;C	27;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1594	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2849	30.1	1	SNP	p	R136L	0	.	.	406	408	CGC	614	616	CGC	29;29;28	C;G;C	27;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1594	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2849	30.1	1	SNP	p	R136H	0	.	.	406	408	CGC	614	616	CGC	29;29;28	C;G;C	27;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1594	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2849	30.1	1	SNP	p	R136I	0	.	.	406	408	CGC	614	616	CGC	29;29;28	C;G;C	27;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1594	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2849	30.1	1	SNP	p	R136E	0	.	.	406	408	CGC	614	616	CGC	29;29;28	C;G;C	27;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1594	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2849	30.1	1	SNP	p	R136G	0	.	.	406	408	CGC	614	616	CGC	29;29;28	C;G;C	27;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	298	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	962	16.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	363	365	CCG	17;17;17	C;C;G	16;17;17	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	298	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	962	16.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	516	518	GCC	20;20;19	G;C;C	20;20;19	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	676	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1292	28.1	0	.	p	.	0	P9S	NONSYN	25	27	CCA	203	205	TCA	27;27;26	T;C;A	27;27;26	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	240	marA	384	384	99.74	marA.l15.c4.ctg.1	757	17.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	503	505	AGC	8;8;7	A;G;C	7;8;7	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	605	607	CAT	5;5;5	C;A;T	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	V45E	0	.	.	133	135	GTG	329	331	GTG	17;18;18	G;T;G	17;17;18	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	I49S	0	.	.	145	147	ATC	341	343	ATC	13;13;13	A;T;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	A70T	0	.	.	208	210	GCA	404	406	GCA	12;12;13	G;C;A	12;12;13	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	R73C	0	.	.	217	219	CGT	413	415	CGT	13;13;13	C;G;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	R73S	0	.	.	217	219	CGT	413	415	CGT	13;13;13	C;G;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	R77L	0	.	.	229	231	CGC	425	427	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	R77C	0	.	.	229	231	CGC	425	427	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	L78M	0	.	.	232	234	CTG	428	430	CTG	11;11;11	C;T;G	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	R94H	0	.	.	280	282	CGC	476	478	CGC	10;10;10	C;G;C	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	R94S	0	.	.	280	282	CGC	476	478	CGC	10;10;10	C;G;C	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	118	marR	435	430	97.67	marR.l15.c4.ctg.1	626	9.6	1	SNP	p	V96E	0	.	.	286	288	GTA	482	484	GTA	9;9;9	G;T;A	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	480	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1493	16.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	35	35	G	20	G	20	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	480	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1493	16.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	92	94	CAG	12;13;12	C;A;G	12;12;12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	480	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1493	16.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	242	244	ATC	10;10;11	A;T;C	10;10;10	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	480	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1493	16.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	290	292	ATG	11;12;12	A;T;G	11;12;12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	480	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1493	16.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	383	385	ACC	16;16;16	A;C;C	14;15;16	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1726	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3417	27.1	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1938	1940	ACC	32;31;34	A;C;C	32;31;34	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1726	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3417	27.1	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2331	2333	CAA	19;19;19	C;A;A,G	19;19;18,1	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1726	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3417	27.1	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2499	2501	ATT	18;18;18	A;T;T	18;18;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1726	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3417	27.1	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2583	2585	GTT	19;19;20	G;T;T	19;18;20	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1726	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3417	27.1	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2691	2693	GAG	16;16;16	G;A;G	16;16;15	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1726	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3417	27.1	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2919	2921	ATG	10;10;11	A;T;G	10;10;11	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1726	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3417	27.1	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3054	3056	GAT	21;23;24	G;A;T	21;23;24	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	1500	mdtC	3078	2902	98.83	mdtC.l6.c4.ctg.1	3085	25.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	319	321	ATG	12;12;12	A;T;G	11;12;12	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	1500	mdtC	3078	2902	98.83	mdtC.l6.c4.ctg.1	3085	25.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	805	807	ATC	31;30;31	A,C;T;C	29,1;29;30	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	1500	mdtC	3078	90	100.0	mdtC.l6.c4.ctg.3	138	10.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	614	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1780	18.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	163	165	GAA	12;12;12	G;A;A	12;12;12	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	614	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1780	18.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	832	834	GCG	16;17;16	G;C;G	16;17;16	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	614	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1780	18.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1174	1176	ATC	29;29;30	A;T;C	28;29;30	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	614	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1780	18.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1477	1479	TTT	21;23;23	T;T;T	21;23;23	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	856	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1548	29.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2188	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3576	32.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1089	1091	ACC	24;24;22	A;C;C	24;23;21	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2188	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3576	32.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2331	2333	GAC	41;42;43	G;A;C	41;41;43	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	676	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1458	20.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	634	636	ATC	33;33;35	A;T;C	33;33;35	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	676	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	365	13.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	186	188	GGA	9;10;9	G;G;A	9;10;9	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	540	mdtH	1209	1209	98.1	mdtH.l15.c4.ctg.1	1541	18.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	591	593	TGT	25;25;25	T;G;T	25;25;25	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	540	mdtH	1209	1209	98.1	mdtH.l15.c4.ctg.1	1541	18.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1161	1163	TTG	20;20;21	T;T;G	19;19;20	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	540	mdtH	1209	1209	98.1	mdtH.l15.c4.ctg.1	1541	18.8	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1266	1268	CAG	6;6;6	C;A;G	6;6;6	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	540	mdtH	1209	1209	98.1	mdtH.l15.c4.ctg.1	1541	18.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1371	1373	ACG	17;17;17	A;C;G	16;17;17	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	806	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1611	26.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	764	766	TCC	16;18;18	T;C;C	16;18;18	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	576	mdtN	1032	1032	98.16	mdtN.l15.c17.ctg.1	1412	21.9	0	.	p	.	0	V119I	NONSYN	355	357	GTT	541	543	ATT	23;23;26	A;T;T	23;23;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	V11M	NONSYN	31	33	GTG	186	188	ATG	12;16;18	A;T;G	12;16;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	T33I	NONSYN	97	99	ACC	252	254	ATC	11;11;12	A,G;T;C	10,1;11;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	C116R	NONSYN	346	348	TGC	501	503	CGC	31;34;34	C;G;C	31;34;34	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	N238S	NONSYN	712	714	AAC	867	869	AGC	28;28;29	A;G;C	27;27;29	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1068	1070	GTG	33;31;32	G;T;G	33;29;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1131	1133	AAC	12;11;11	A;A;C	12;10;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1176	1178	GTC	23;25;25	G;T;C	23;23;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1206	1208	ATA	28;27;27	A;T;A	28;27;26	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1314	1316	TCT	23;22;22	T;C;T	22;22;22	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1701	1703	GCG	29;31;32	G;C;G	29;31;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1196	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2370	27.1	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1914	1916	ATC	28;28;28	A;T;C	28;28;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	S129A	NONSYN	385	387	TCA	564	566	GCG	17;17;18	G;C;G	16;17;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	A187T	NONSYN	559	561	GCC	738	740	ACC	21;22;21	A;C;C	20;22;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	H211R	NONSYN	631	633	CAC	810	812	CGC	28;30;30	C;G;C	28;30;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	V250A	NONSYN	748	750	GTT	927	929	GCT	35;35;35	G;C;T	35;35;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1011	1013	AAA	15;13;13	A;A;A	14;13;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1029	1031	CGA	12;10;10	C;G;A	12;10;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1194	1196	GCC	14;15;15	G;C;C	14;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1206	1208	GAT	15;16;16	G;A;T	15;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	704	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1852	20.4	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1623	1625	GCT	7;8;7	G;C;T	7;8;7	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1758	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3839	24.6	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1494	1496	AAG	19;20;20	A;A;G	19;20;20	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1758	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3839	24.6	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2571	2573	CTG	17;17;16	C;T;G	17;17;16	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	132	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	167	21.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1112	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2095	28.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	974	976	AAC	28;31;31	A;A;C	28;31;31	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1112	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2095	28.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1520	1522	ATA	24;24;24	A;T;A	24;24;24	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	862	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1732	26.7	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1251	1253	GTG	37;37;37	G;T;G	37;37;37	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	862	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1732	26.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1329	1331	GAT	34;34;34	G;A;T	34;33;34	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	862	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1732	26.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1332	1334	CTG	35;34;34	C;T;G	35;33;34	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	868	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1485	31.2	1	SNP	p	G141E	0	.	.	421	423	GGT	605	607	GGT	41;41;40	G;G;T	41;41;40	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	868	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1485	31.2	1	SNP	p	G141D	0	.	.	421	423	GGT	605	607	GGT	41;41;40	G;G;T	41;41;40	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	868	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1485	31.2	1	SNP	p	R154A	0	.	.	460	462	CGT	644	646	CGT	38;39;39	C;G;T	38;39;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	868	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1485	31.2	1	SNP	p	R154D	0	.	.	460	462	CGT	644	646	CGT	38;39;39	C;G;T	38;39;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1692	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2705	33.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1851	1853	TCG	41;40;39	T;C;G	41;39;39	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1692	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2705	33.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2466	2468	AAC	17;18;19	A;A;C	17;18;19	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1692	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2705	33.6	1	SNP	p	A85T	0	.	.	253	255	GCG	480	482	GCG	41;39;38	G;C;G	41;39;38	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1692	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2705	33.6	1	SNP	p	D111H	0	.	.	331	333	GAT	558	560	GAT	25;25;25	G;A;T	25;25;25	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1692	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2705	33.6	1	SNP	p	S129P	0	.	.	385	387	TCC	612	614	TCC	44;45;47	T;C;C	44;45;47	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	928	parE_1	1893	1893	97.57	parE_1.l15.c30.ctg.1	2148	22.7	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1490	1492	GAT	35;35;35	G;A;T	35;35;35	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	944	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1784	28.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1287	1289	GAT	35;35;35	G;A;T	34;34;35	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	0	.	p	.	0	Q148R	NONSYN	442	444	CAG	644	646	CGG	26;27;22	C;G;G	26;27;22	.	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	V146F	0	.	.	436	438	GTT	638	640	GTT	30;29;27	G;T;T	30;29;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1739	1741	CAG	36;36;38	C;A;G	36;36;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1739	1741	CAG	36;36;38	C;A;G	36;36;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1778	1780	CAC	30;29;29	C;A;C	30;29;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1787	1789	CGT	29;29;29	C;G;T	29;28;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1787	1789	CGT	29;29;29	C;G;T	29;28;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1793	1795	TCC	30;30;28	T;C;C	30;30;28	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1799	1801	CTC	28;27;25	C;T;C	27;27;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1889	1891	ACC	34;34;34	A;C;C	34;34;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1892	1894	CCT	34;32;34	C;C;T	34;32;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	3202	rpoB	4029	4029	99.01	rpoB.l15.c30.ctg.1	4458	38.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2261	2263	CGT	66;64;61	C;G;T	66;64;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	.	n	.	0	A226G	SNP	226	226	A	396	396	G	277	G	276	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	1	SNP	n	A794G	0	.	.	794	794	A	964	964	A	220	A	217	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	1	SNP	n	A794T	0	.	.	794	794	A	964	964	A	220	A	217	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	1	SNP	n	G926A	0	.	.	926	926	G	1096	1096	G	234	G	234	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	1	SNP	n	G926C	0	.	.	926	926	G	1096	1096	G	234	G	234	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	1	SNP	n	G926T	0	.	.	926	926	G	1096	1096	G	234	G	234	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	1689	1689	A	208	A	207	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	1689	1689	A	208	A	207	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	1689	1689	A	208	A	207	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	C183T	.	183	183	C	353	353	C	209	C,T	136,72	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	T90C	.	90	90	T	260	260	T	188	T,C	143,42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	A250T	.	250	250	A	420	420	A	244	A,T	183,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	G474A	.	474	474	G	644	644	G	249	G,A	191,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	A253T	.	253	253	A	423	423	A	251	A,T	190,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	C194T	.	194	194	C	364	364	C	230	C,T	172,55	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	G1002A	.	1002	1002	G	1172	1172	G	224	G,A	160,63	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	C719T	.	719	719	C	889	889	C	233	C,T	143,88	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	G1006C	.	1006	1006	G	1176	1176	G	220	G,C	154,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	A79G	.	79	79	A	249	249	A	218	A,G	161,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	C1038T	.	1038	1038	C	1208	1208	C	230	C,T	174,55	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	T273A	.	273	273	T	443	443	T	231	T,A	163,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	7712	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1869	215.9	0	HET	.	.	.	T1010C	.	1010	1010	T	1180	1180	T	227	T,C	159,65	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	392	soxR	465	465	100.0	soxR.l15.c30.ctg.1	813	25.8	1	SNP	p	R20H	0	.	.	58	60	CGC	224	226	CGC	31;31;29	C;G;C	31;30;29	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	392	soxR	465	465	100.0	soxR.l15.c30.ctg.1	813	25.8	1	SNP	p	G121D	0	.	.	361	363	GGT	527	529	GGT	36;36;37	G;G;T	36;36;37	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	282	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	749	20.3	1	SNP	p	A12S	0	.	.	34	36	GCA	237	239	GCA	39;40;40	G;C;A	39;40;40	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1010	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1936	28.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
